Clinical Trial Update: Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a mixed HEXA/PENTA/HEXA schedule (V419-010) completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Neisseria Meningitidis
• Virus Diseases

Drugs mentioned

• HEXA/PENTA/HEXA schedule V419-010

Snippet

Sponsor: MCM Vaccines B.V. | Conditions: Neisseria Meningitidis, Bacterial Infections | Phase 3 | Status: COMPLETED | Results posted: 2019-02-25